SK4022000A3 - PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS - Google Patents

PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS Download PDF

Info

Publication number
SK4022000A3
SK4022000A3 SK402-2000A SK4022000A SK4022000A3 SK 4022000 A3 SK4022000 A3 SK 4022000A3 SK 4022000 A SK4022000 A SK 4022000A SK 4022000 A3 SK4022000 A3 SK 4022000A3
Authority
SK
Slovakia
Prior art keywords
factor
preparation according
protein
factors
preparation
Prior art date
Application number
SK402-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Yendra Linnau
Peter Turecek
Hans-Peter Schwarz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of SK4022000A3 publication Critical patent/SK4022000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK402-2000A 1997-09-19 1998-09-17 PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS SK4022000A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0159197A AT409334B (de) 1997-09-19 1997-09-19 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
PCT/AT1998/000224 WO1999015196A1 (de) 1997-09-19 1998-09-17 Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren

Publications (1)

Publication Number Publication Date
SK4022000A3 true SK4022000A3 (en) 2000-09-12

Family

ID=3516739

Family Applications (1)

Application Number Title Priority Date Filing Date
SK402-2000A SK4022000A3 (en) 1997-09-19 1998-09-17 PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS

Country Status (10)

Country Link
EP (1) EP1015020A1 (pt)
JP (1) JP2001517636A (pt)
AT (1) AT409334B (pt)
AU (1) AU743102B2 (pt)
BR (1) BR9812222A (pt)
CA (1) CA2304396A1 (pt)
HU (1) HUP0003681A1 (pt)
NO (1) NO20001415L (pt)
SK (1) SK4022000A3 (pt)
WO (1) WO1999015196A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0402315A3 (en) 2001-12-21 2009-03-30 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
EP1485121A4 (en) * 2002-03-08 2007-11-07 Lilly Co Eli ACTIVE C PROTEIN FORMULATIONS
CN1671410B (zh) 2002-06-21 2010-05-12 诺和诺德医疗保健公司 因子ⅶ多肽的稳定化固体组合物
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
AU2004241698A1 (en) 2003-05-23 2004-12-02 Novo Nordisk Health Care Ag Protein stabilization in solution
ES2382157T3 (es) 2003-06-25 2012-06-05 Novo Nordisk Health Care Ag Composición líquida de polipépttidos del factor VII
CA2534028A1 (en) 2003-08-14 2005-02-24 Novo Nordisk Health Care Ag Liquid, aqueous pharmaceutical composition of factor vii polypeptides
EP3378470A1 (en) 2003-12-19 2018-09-26 Novo Nordisk Health Care AG Stabilised compositions of factor vii polypeptides
CN101151533A (zh) * 2005-02-16 2008-03-26 伊利诺斯大学理事会 基于金属螯合脂质的促凝血剂
DE602006021290D1 (de) 2005-03-04 2011-05-26 Univ Illinois Modulator von coagulationskaskaden und fibrinolytischen kaskaden
WO2009046194A2 (en) 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
EP2624859B1 (en) 2010-10-06 2017-03-01 Medimmune Limited Factor ii alone or in combination with further factors for treatment of impaired haemostasis associated with dilutional coagulopathy
KR102658958B1 (ko) * 2017-02-09 2024-04-22 체에스엘 베링 게엠베하 출혈의 치료 또는 예방에 사용하기 위한 혈액 응고 인자 대체품

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
IT1262899B (it) * 1992-03-27 1996-07-22 Sclavo Spa Processo per l'isolamento di fattore ix, fattore x e fattore ii altamente purificati dal complesso protrombinico o dal plasma umano
DE4342132C1 (de) * 1993-12-10 1994-11-03 Octapharma Ag Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DK0796623T3 (da) * 1996-03-20 2005-08-01 Baxter Ag Farmaceutisk præparat til behandling af blodkoagulationslidelser

Also Published As

Publication number Publication date
EP1015020A1 (de) 2000-07-05
AU9244998A (en) 1999-04-12
AU743102B2 (en) 2002-01-17
BR9812222A (pt) 2000-07-18
CA2304396A1 (en) 1999-04-01
JP2001517636A (ja) 2001-10-09
AT409334B (de) 2002-07-25
WO1999015196A1 (de) 1999-04-01
NO20001415L (no) 2000-05-19
HUP0003681A1 (hu) 2001-02-28
ATA159197A (de) 2001-12-15
NO20001415D0 (no) 2000-03-17

Similar Documents

Publication Publication Date Title
CA2287267C (en) Improved methods for processing activated protein c
JP5025868B2 (ja) 可逆的に不活性な酸性化プラスミン組成物の調製法
AU758152B2 (en) Pharmaceutical factor VII preparation
US7767647B2 (en) Method of the invention preparations of factor IXa
SK4022000A3 (en) PHARMACEUTICAL SUBSTANCE CONTAINING VARIOUS VITAMIN K-DEPENDENTì (54) FACTORS
JP3032085B2 (ja) プロテインｃを含有し血栓溶解活性を有する非経口投与が可能な薬剤
US6358534B1 (en) Immunotolerant prothrombin complex preparation
Michalski et al. Large‐scale production and properties of a solvent‐detergent‐treated factor IX concentrate from human plasma
JP5261478B2 (ja) 第Ｘ因子，活性化第Ｘ因子，不活性第Ｘ因子および不活性化第Ｘａ因子の調製方法、ならびに該因子を含む医薬組成物
US6043215A (en) Preparation of factor IX
JPH1059866A (ja) 血液凝固第ｖｉｉ因子及び／もしくは活性化血液凝固第ｖｉｉ因子の製造方法
US5254532A (en) Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
US5143901A (en) Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
US6403556B1 (en) Pharmaceutical preparation containing protein C and a thrombolytically active substance
US5945103A (en) Process for producing thrombin
EP0139447A2 (en) A process for preparing urokinase zymogen
CZ2000982A3 (cs) Farmaceutický preparát obsahující jednotlivé faktory, závislé na vitaminu K a jeho použití
MXPA00002622A (es) Preparado farmaceutico que contiene factores individuales dependientes de la vitamina k
McGrath Factor IX (protease zymogen)
EP1557463A1 (en) Improved methods for processing activated protein C
MXPA99008941A (es) Preparacion del complejo de protrombina inmunotolerante
CZ355899A3 (cs) Imunotolerantní farmaceutické přípravky prothrombinového komplexu, způsob jejich výroby a jejich použití
AU1564902A (en) Improved methods for processing activated protein C